HER2 Equivocal: What an Uncertain HER2 Result Means

When a HER2 test comes back equivocal, it means the result is uncertain — not clearly positive and not clearly negative. The lab could not make a firm call from that test, so more testing is needed before your care team can use the HER2 result to plan your treatment. This is a routine and expected part of HER2 testing, not an error or a bad sign.

This guide explains what “equivocal” actually means, why it happens, what testing comes next, and what questions to bring to your doctor. The key idea: an equivocal result is a pause for clarity, not a verdict.

Key Takeaways

Equivocal means the HER2 test result was borderline — neither clearly positive nor clearly negative.
It happens most often on the first test (IHC), which then triggers a second test (FISH) for a clearer answer.
Equivocal is an expected part of the two-step HER2 testing process, not a mistake.
Treatment decisions that depend on HER2 wait until the result is confirmed.
If testing remains unclear, the result may be reported as indeterminate, and your care team will explain what that means for your plan.
You do not need to act on an equivocal result — your care team orders and interprets the follow-up testing.

What “Equivocal” Means

In everyday language, “equivocal” means unclear or open to more than one interpretation. In a lab report, it means exactly that: the pathologist looked at the test result and could not honestly call it positive or negative. The measurement landed in the middle zone where neither answer is reliable.

HER2 testing starts with a test called IHC (immunohistochemistry), which stains the tissue sample and scores how much HER2 protein the cells display. The score runs from 0 to 3+. A score of 0 or 1+ is read as negative. A score of 3+ is read as positive. A score of 2+ is the equivocal zone — more staining than a negative result, less than a positive one.

Here is the part that matters: the testing process is designed with this middle zone in place on purpose. The lab expects some results to land there, and the process has a built-in next step ready to go. So if your report says “HER2 equivocal,” it means the first test did its job — including the part where it flags results that need a closer look.

A woman in a light cardigan speaking with her oncologist in a bright consultation room

Why HER2 Testing Comes in Two Steps

HER2 status carries real weight in treatment planning, so the medical community built a testing approach that favors certainty over speed. Rather than one test that must give a yes-or-no answer every time, the process uses a screening test first and a more detailed test to resolve the borderline cases.

The first test, IHC, is fast and widely available. It handles the clear cases well — the strongly positive and the clearly negative. The second test, FISH (fluorescence in situ hybridization), looks at the genes behind the protein instead of the protein itself. It counts copies of the HER2 gene inside the cells, which gives a more precise answer when the protein staining is in between.

This two-step design explains why an equivocal IHC result is not a dead end but a junction. The system was built knowing that the first test would produce middle-zone results, and the second test exists precisely to sort them out. Most patients never need to think about this; if you are reading this, you are in the group for whom the second test does its quiet, important work.

What Happens After an Equivocal Result

After an equivocal IHC result, the usual next step is reflex FISH testing — “reflex” meaning it happens automatically, without anyone needing to order it separately or you needing to give another sample. The lab runs the FISH test on the same tissue. You typically do not need another biopsy or another appointment.

The FISH test takes longer than IHC because it involves more detailed analysis. During this waiting period, there is nothing you need to do. Your care team knows the result is pending and will factor the final answer into the treatment plan once it arrives.

FISH results are reported in their own terms — positive, negative, or in some cases still equivocal or indeterminate if the gene counting is itself borderline. The table below summarizes the possible paths:

Step	Result	What happens next
IHC (first test)	Negative (0 or 1+)	HER2 is considered negative; no further HER2 testing needed
IHC (first test)	Equivocal (2+)	Reflex FISH testing on the same tissue sample
IHC (first test)	Positive (3+)	HER2 is considered positive; no further HER2 testing needed
FISH (second test)	Negative	HER2 is considered negative
FISH (second test)	Positive	HER2 is considered positive
FISH (second test)	Equivocal or indeterminate	Reported as such; your care team explains how the plan accounts for the uncertainty

In rare cases, the final result remains indeterminate — the honest lab answer when the evidence genuinely does not settle the question. If that happens, your care team will talk with you about how they are weighing the rest of your pathology information. An indeterminate result does not mean treatment stops; it means the plan is built around everything else that is known.

Our detailed guide to IHC and FISH testing walks through both tests step by step.

Two women walking side by side through a sunlit park, talking quietly

What Equivocal Does Not Mean

Because “equivocal” is an unfamiliar word, it is easy to read more into it than is there. A few clarifications:

It does not mean the cancer is more serious. Equivocal describes the test, not the cancer. It says nothing about size, stage, grade, or behavior.
It does not mean the lab made a mistake. The middle zone is a designed part of the test, and flagging it is the correct result for that sample.
It does not mean you need a new biopsy. The follow-up test uses the same tissue in the large majority of cases.
It does not mean treatment is delayed in a harmful way. Treatment planning takes time for many reasons, and the wait for a confirmed HER2 result is a normal part of that timeline.
It does not predict the final answer. An equivocal IHC result can resolve as either positive or negative on FISH. There is no point in guessing which way it will go.

If anxiety fills the waiting period — and it often does — that is understandable. The uncertainty is about a lab measurement, not about your worth or your future, and naming that distinction can sometimes make the wait a little easier to carry.

Reading the Final Result

Once all testing is complete, your HER2 result will appear in the pathology report — sometimes in the original report, sometimes in an addendum if the FISH test finished later. The final result is what your care team uses in treatment planning.

If the final result is HER2-positive, medicines designed to target HER2 enter the treatment conversation. If it is HER2-negative, the conversation focuses on other approaches suited to your hormone-receptor status and the rest of your pathology. Your doctor will explain which parts of the plan connect to the HER2 result and which connect to other features of your cancer.

It is worth knowing that HER2 testing is also sometimes repeated — on tissue removed during surgery, or if the cancer returns. If you see a second HER2 result that differs from the first, that is a topic for your care team, not a cause for alarm on its own. Tissue samples can vary, and doctors account for that.

Our guide to how breast cancer is found and diagnosed places HER2 testing within the full diagnostic journey.

Questions to Ask Your Doctor

An equivocal result is a good reason to ask for clarity. Consider bringing these questions:

My report says HER2 is equivocal — what testing is happening next, and when will we have the final result?
Will the follow-up test use my existing tissue sample, or is another sample needed?
How does the final HER2 result affect the treatment options you are considering?
If the result stays indeterminate, how would that change the plan?
Was any other part of my pathology — hormone receptors, grade — affected by this uncertainty, or is it only the HER2 result?
Who will explain the final result to me, and should I plan a separate appointment for that?

Individual cases differ, and the details of your testing timeline belong to your care team. Asking these questions simply keeps you informed while the lab does its work.

Frequently Asked Questions

How long does FISH testing take after an equivocal IHC?

It generally takes longer than the initial IHC — often on the order of days to a couple of weeks, depending on the lab. Your care team can give you a realistic timeline for your specific lab. The wait is normal and does not require any action from you.

Can I start treatment while the HER2 result is still pending?

That is a decision for your care team, based on your whole situation. Some parts of planning move forward regardless; decisions that depend specifically on HER2 wait for the confirmed result. If you are worried about timing, ask your doctor directly how the schedule works.

What is the difference between equivocal and indeterminate?

They are close cousins. “Equivocal” usually describes the IHC 2+ result that triggers FISH. “Indeterminate” usually describes a final report where even the follow-up testing could not settle the question. Both mean uncertainty that your care team accounts for openly.

Should I get a second opinion on an equivocal result?

Second opinions on pathology are your right, and some patients request them for peace of mind. That said, an equivocal result is itself the careful answer — the lab is saying “we need a closer look,” not making a guess. The follow-up FISH test is, in a sense, the built-in second look.

Will an equivocal result affect my prognosis?

The equivocal label itself does not. What matters is the final confirmed result and everything else in your pathology — stage, grade, hormone receptors, and your overall health. Prognosis is never read from a single test result, and your doctor is the right person to discuss what your complete picture means.

Why didn’t the lab just do FISH first?

IHC is faster, simpler, and resolves most cases clearly. Running FISH on every sample would add time and cost without changing the answer for the majority. The two-step approach reserves the more detailed test for the cases that actually need it — including yours.

This article is for general educational purposes only and is not medical, legal, or financial advice. It does not replace professional care. Talk to your doctor or care team about your own situation. If you think you may have a medical emergency, call 911.